Results 161 to 170 of about 141,920 (316)

Association Between Dietary Advanced Glycation End Products (AGEs) and Pancreatic Fat Accumulation: Evidence From a Case-Control Study. [PDF]

Endocrinol Diabetes Metab
Shahparvari MR, Yari Z, Chegini M, Bahrizadeh M, Sadeghi A, Hekmatdoost A.   +5 more
europepmc   +1 more source

Comparative Diagnostic Performance of Metabolic Scoring Indices for Ultrasonographic Hepatic Steatosis: Development and Validation of a Novel Composite Score in 1204 Consecutive Patients. [PDF]

J Clin Med
Altun G, Çiftel E.
europepmc   +1 more source

Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk

International Journal of Gynecology &Obstetrics, EarlyView.
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park, Keungmo Yang, Hyun Yang, Si Hyun Bae, Mee‐Ran Kim, Jaejun Lee   +5 more
wiley   +1 more source

Glucagon-like peptide-1 agonists usage to widen the living donor pool for liver transplantation: A novel metabolic strategy. [PDF]

World J Transplant
Alnagar A, Khan MU, Ahmad MS, Mersal M, Ayyad M, Hassan R, Noormohamed MS.   +6 more
europepmc   +1 more source

Effect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trial. [PDF]

PLoS One
Jespersen S, Fritt-Rasmussen A, Durrer CG, Fallentin E, Andersen ES, Thielsen P, Bandholm T, Madsbad S, Pedersen BK, Ritz C, Weis N, Krogh-Madsen R.   +11 more
europepmc   +1 more source

Non‐Nutritive Artificial Sweeteners Aspartame and Acesulfame‐K Ameliorate Metabolic Dysfunction‐Associated Steatotic Liver Disease in Male Ldlr−/− Mice

iNew Medicine, EarlyView.
ABSTRACT Aspartame and acesulfame‐K are commonly used non‐nutritive artificial sweeteners, but their impacts on cardiovascular disease and metabolic dysfunction‐associated fatty liver disease (MASLD) are unclear. In this study, we evaluated the impacts of aspartame and acesulfame‐K on MASLD and atherosclerosis in male Ldlr−/− mice fed an AMLN diet ...
Jingjing Xu, Xiaohua Jiang, Jianping Weng, Suowen Xu   +3 more
wiley   +1 more source

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes. [PDF]

Liver Int
Del Barrio M, Sala M, Gómez J, Horta D, Hernández-Guerra M, Salcedo M, Goñi S, Ríos-León R, Herreros ÁM, González-Santiago JM, Martínez J, Quintans NC, Ampuero J, Antón MD, Fernández-de la Varga M, Escudero D, El Hajra I, Cuenca Alarcón F, Lorente S, Andrade RJ, Riveiro-Barciela M, Castello I, Vergara M, Quiñones R, Arencibía Almeida A, Blanco Sampascual S, Leal C, García-Retortillo M, Pérez-Medrano I, Fernández-Bermejo M, Morillas RM, Gómez E, Tejedor-Tejada J, Roget M, Rodríguez-Tajes S, Alonso-Peña M, Álvarez-Cancelo A, Londoño MC, Díaz-González Á.   +38 more
europepmc   +1 more source

Zinc Finger E‐Box Binding Homeobox 1 Mediates Alcohol‐Induced Liver Disease

iNew Medicine, EarlyView.
Alcohol intake leads to the upregulation of ZEB1, which activates the YAP‐IL‐1β/MCP‐1 pathway, resulting in the activation of liver inflammation and the induction of hepatocyte apoptosis. ABSTRACT Hepatitis resulting from alcoholic liver disease (ALD) is an important risk factor for liver cancer. It is essential to understand the role of ALD to prevent
Boyu Zhang, Chunyang Zhang, Xiao Cui, Tao Xu, Xiangpeng Hu, Jiong Gu   +5 more
wiley   +1 more source

Selenium and Liver Steatosis and Fibrosis: Opposing Direct and Steatosis-Mediated Associations in a Large Cohort. [PDF]

JGH Open
Rehan N, Benedict J, Qayyum R.
europepmc   +1 more source

Western Diet Combined With Chemical Induction: A Strategy for Rapid Development of MASLD Pathology in Mice

iNew Medicine, EarlyView.
ABSTRACT The molecular mechanisms underlying the development of metabolic‐dysfunction‐associated steatotic liver disease (MASLD) are essential for developing appropriate treatments. The purpose of this study was to establish an MASLD model in mice with rapid and consistent progression.
Ting‐Ting Chen, Nan Li, Shuo Wang, Miao Sun, Rui Yang, Shi‐Hao Zhang, Xiao‐Lei Li, Chen Dong, Ke‐Yuan Chen, Wu‐Yi Sun, Na Zhou   +10 more
wiley   +1 more source